Discovery of eucalyptus essential oil as a novel colistin adjuvant eradicate multidrug-resistant Gram-negative bacteria
Microbial Pathogenesis · 2026
DOI: 10.1016/j.micpath.2026.108389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Yuzhu Pei und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Colistin, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Gram-Negative Bacteria. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Pei, Y., Qi, K., Zhou, Y., Xu, L., Wang, J., Deng, X., Ding, L., & Deng, Y. (2026). Discovery of eucalyptus essential oil as a novel colistin adjuvant eradicate multidrug-resistant Gram-negative bacteria. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108389
Vancouver
Pei Y, Qi K, Zhou Y, Xu L, Wang J, Deng X, et al. Discovery of eucalyptus essential oil as a novel colistin adjuvant eradicate multidrug-resistant Gram-negative bacteria. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108389
BibTeX
@article{Pei2026,
author = {Pei, Yuzhu and Qi, Kaige and Zhou, Yutong and Xu, Lei and Wang, Jianfeng and Deng, Xuming and Ding, Linlin and Deng, Yanhong},
title = {Discovery of eucalyptus essential oil as a novel colistin adjuvant eradicate multidrug-resistant Gram-negative bacteria},
journal = {Microbial Pathogenesis},
year = {2026},
doi = {10.1016/j.micpath.2026.108389}
}
EUVIMED